Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus is safe within the first month after liver transplantation.
Rodríguez-Perálvarez M, Pérez-Medrano I, Guerrero-Misas M, González V, Poyato A, Barrera P, Ferrín G, Pozo JC, Sánchez-Frías M, Ciria R, Briceño J, Montero JL, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: barrera p. Transpl Immunol. 2015 Oct;33(2):146-51. doi: 10.1016/j.trim.2015.09.002. Epub 2015 Sep 24. Transpl Immunol. 2015. PMID: 26392195
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy.
Rodríguez-Perálvarez M, García-Caparrós C, Tsochatzis E, Germani G, Hogan B, Poyato-González A, O'Beirne J, Senzolo M, Guerrero-Misas M, Montero-Álvarez JL, Patch D, Barrera P, Briceño J, Dhillon AP, Burra P, Burroughs AK, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: barrera p. Transpl Int. 2015 Apr;28(4):455-64. doi: 10.1111/tri.12514. Epub 2015 Jan 16. Transpl Int. 2015. PMID: 25557691 Free article.
[Prognostic factors associated with postoperative complications in liver transplant].
Rodríguez-Ariza A, Monrobel A, Martínez-Galisteo E, Alicia Padilla C, Bárcena JA, Fraga E, Costán G, Barrera P, Poyato A, Montero JL, López-Cillero P, Muntané J, de la Mata M. Rodríguez-Ariza A, et al. Among authors: barrera p. Rev Esp Enferm Dig. 2008 Mar;100(3):129-38. doi: 10.4321/s1130-01082008000300002. Rev Esp Enferm Dig. 2008. PMID: 18416637 Free article. Spanish.
mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence.
Guerrero M, Ferrín G, Rodríguez-Perálvarez M, González-Rubio S, Sánchez-Frías M, Amado V, Pozo JC, Poyato A, Ciria R, Ayllón MD, Barrera P, Montero JL, de la Mata M. Guerrero M, et al. Among authors: barrera p. Int J Mol Sci. 2019 Jan 15;20(2):336. doi: 10.3390/ijms20020336. Int J Mol Sci. 2019. PMID: 30650598 Free PMC article.
[Liver transplantation in patients with HIV infection].
de la Mata M, Barrera P, Fraga E, Montero JL, de la Torre J, López-Cillero P, Briceño J, Solórzano G, Alonso M. de la Mata M, et al. Among authors: barrera p. Gastroenterol Hepatol. 2004 Aug-Sep;27(7):425-8. doi: 10.1016/s0210-5705(03)70492-0. Gastroenterol Hepatol. 2004. PMID: 15461943 Review. Spanish. No abstract available.
Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.
Bernal E, Montero JL, Delgado M, Fraga E, Costán G, Barrera P, López-Vallejos P, Solórzano G, Rufián S, Briceño J, Padillo J, López-Cillero P, Marchal T, Muntané J, de la Mata M. Bernal E, et al. Among authors: barrera p. Transplant Proc. 2006 Oct;38(8):2495-8. doi: 10.1016/j.transproceed.2006.08.053. Transplant Proc. 2006. PMID: 17097979
Control of blood pressure in liver transplant recipients.
Martínez-Saldivar B, Prieto J, Berenguer M, de la Mata M, Pons JA, Serrano T, Rafael-Valdivia L, Aguilera V, Barrera P, Parrilla P, Lorente S, Rubin A, Fraga E, Rimola A. Martínez-Saldivar B, et al. Among authors: barrera p. Transplantation. 2012 May 27;93(10):1031-7. doi: 10.1097/TP.0b013e31824cd5e6. Transplantation. 2012. PMID: 22411562
165 results